Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Receivables (2020 - 2021)

Historic Receivables for Candel Therapeutics (CADL) over the last 2 years, with Q4 2021 value amounting to $1.1 million.

  • Candel Therapeutics' Receivables rose 7243.59% to $1.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 7243.59%. This contributed to the annual value of $1.1 million for FY2021, which is 7243.59% up from last year.
  • Per Candel Therapeutics' latest filing, its Receivables stood at $1.1 million for Q4 2021, which was up 7243.59% from $191000.0 recorded in Q1 2021.
  • In the past 5 years, Candel Therapeutics' Receivables ranged from a high of $1.1 million in Q4 2021 and a low of $191000.0 during Q1 2021